NCT06150664 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06150664
Title	A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Compass Therapeutics
Indications	oral squamous cell carcinoma melanoma hypopharynx cancer lung non-small cell carcinoma triple-receptor negative breast cancer head and neck squamous cell carcinoma oropharynx cancer laryngeal squamous cell carcinoma Hodgkin's lymphoma
Therapies	CTX-8371
Age Groups:	adult \| senior
Covered Countries	USA

NCT06150664
Clinical Trial Detail